These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

83 related articles for article (PubMed ID: 1087085)

  • 21. [Significance of antinuclear antibodies in overlap syndromes. I. Relationship between systemic lupus erythematosus, diffuse scleroderma and dermatomyositis].
    Zitnan D; Rovenský J; Cebecauer L; Hajzok O
    Fysiatr Revmatol Vestn; 1973 Jun; 51(3):152-7. PubMed ID: 4592583
    [No Abstract]   [Full Text] [Related]  

  • 22. [Titers of C 3 factor of serum complement in various autoimmune diseases].
    Lehman C; Andreis M; Bennett L; Godoy G
    Rev Med Chil; 1972; 100(5):497-501. PubMed ID: 4625016
    [No Abstract]   [Full Text] [Related]  

  • 23. [The immuno-fluorescent method in study of lupus erythematosus].
    Rodshteĭn OA; Zubzhitskiĭ IuN
    Ter Arkh; 1968 Aug; 40(8):56-60. PubMed ID: 4194898
    [No Abstract]   [Full Text] [Related]  

  • 24. [Blood cholesterol level in rheumatic diseases].
    Jajić I
    Reumatizam; 1967; 14(3):91-7. PubMed ID: 6045925
    [No Abstract]   [Full Text] [Related]  

  • 25. The immunofluorescent tumor imprint technique. IV. The significance of "thready" nuclear immunofluorescence.
    Burnham TK; Neblett TR; Fine G; Bank P
    Arch Dermatol; 1969 May; 99(5):611-6. PubMed ID: 4889089
    [No Abstract]   [Full Text] [Related]  

  • 26. Detection of human antinuclear antibodies on rodent omenta.
    Holub M
    Allerg Immunol (Leipz); 1982; 28(2):118-21. PubMed ID: 6182782
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Significance of anti-centromere antibodies. Clinical value].
    Meyer O; Haim T; Ryckewaert A
    Rev Rhum Mal Osteoartic; 1983 Apr; 50(4):261-6. PubMed ID: 6348931
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Antinuclear antibodies in disseminated lupus erythematosus and other connective tissue diseases].
    Velasco M; Losada M; Losada A; Ramirez G
    Rev Med Chil; 1968 Aug; 96(8):517-21. PubMed ID: 4915546
    [No Abstract]   [Full Text] [Related]  

  • 29. [Demonstration of antinuclear antibodies in the epidermis of patients with progressive systemic sclerosis, generalized lupus erythematosus and dermatomyositis].
    Lamas Robles C; Mejía Arreguín S; Orozco Medina JH; González Mendoza A
    Rev Invest Clin; 1984; 36(2):115-9. PubMed ID: 6385174
    [No Abstract]   [Full Text] [Related]  

  • 30. [Antinuclear factors. Demonstration and clinico-diagnostic significance].
    Maas D
    Med Klin; 1969 Jul; 64(29):1302-7. PubMed ID: 4184549
    [No Abstract]   [Full Text] [Related]  

  • 31. [Morphologic and immunomorphologic studies in rheumatoid arthritis and systemic lupus erythematosus].
    Wagner T
    Patol Pol; 1984; 35(1):45-64. PubMed ID: 6333663
    [No Abstract]   [Full Text] [Related]  

  • 32. Anti-NuMA antibodies: an uncommon specificity in scleroderma sera.
    Herrera-Esparza R; Avalos-Diaz E; Barbosa-Cisneros O
    Rev Rhum Engl Ed; 1999 Jun; 66(6):315-8. PubMed ID: 10418059
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Rheumatoid arthritis and systemic lupus erythematosus (SLE).
    Beer TC; Gumpel JM
    Proc R Soc Med; 1973 Sep; 66(9):910. PubMed ID: 4141773
    [No Abstract]   [Full Text] [Related]  

  • 34. [Current immunological diagnosis of collagenoses. I. Systemic lupus erythematosus and systemic scleroderma].
    Jarzabek-Chorzelska M; Kołacińska-Strasz Z; Błaszczyk M; Chorzelski T; Jabłońska S
    Przegl Dermatol; 1987; 74(6):421-30. PubMed ID: 3330246
    [No Abstract]   [Full Text] [Related]  

  • 35. [Value of lupus biology in rheumatoid polyarthritis].
    Bardin T
    Ann Med Interne (Paris); 1984; 135(6):411-3. PubMed ID: 6334464
    [No Abstract]   [Full Text] [Related]  

  • 36. [Routine immunofluorescence examinations for the demonstration of antinuclear factors].
    Hiemann D
    Z Gesamte Inn Med; 1969 Jan; 24(1):Suppl:150-1. PubMed ID: 4918616
    [No Abstract]   [Full Text] [Related]  

  • 37. [Differentiation with immunofluorescence of complement fixing and non-fixing antinuclear factors in patients with and without disseminated lupus erythematosus].
    Peltier AP
    Pathol Biol; 1968 Apr; 16(7):439-44. PubMed ID: 4882383
    [No Abstract]   [Full Text] [Related]  

  • 38. [Differentiation of autoantibodies to extractable nuclear antigens using immunoblotting in various collagen diseases].
    Riemekasten G; Hiepe F
    Z Arztl Fortbild (Jena); 1992 Mar; 86(5):217-22. PubMed ID: 1585674
    [No Abstract]   [Full Text] [Related]  

  • 39. The relative value of antibody assays in the differential diagnosis of systemic lupus erythematosus and rheumatoid arthritis with special emphasis to ultramicro ELISA for anti-ds DNA.
    Wollina U
    Dermatol Monatsschr; 1984; 170(10):645-7. PubMed ID: 6391968
    [No Abstract]   [Full Text] [Related]  

  • 40. Patterns of nuclear fluorescence and DNA-binding activity.
    Luciano A; Rothfield NF
    Ann Rheum Dis; 1973 Jul; 32(4):337-41. PubMed ID: 4580007
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.